GALAPAGOS NV-SPON ADR (GLPG) Stock Fundamental Analysis

NASDAQ:GLPG • US36315X1019

33.92 USD
+0.49 (+1.47%)
At close: Feb 13, 2026
33.92 USD
0 (0%)
After Hours: 2/13/2026, 8:13:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall GLPG gets a fundamental rating of 2 out of 10. We evaluated GLPG against 523 industry peers in the Biotechnology industry. The financial health of GLPG is average, but there are quite some concerns on its profitability. GLPG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year GLPG has reported negative net income.
  • GLPG had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: GLPG reported negative net income in multiple years.
  • GLPG had a negative operating cash flow in each of the past 5 years.
GLPG Yearly Net Income VS EBIT VS OCF VS FCFGLPG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

  • GLPG's Return On Assets of -12.42% is amongst the best of the industry. GLPG outperforms 82.41% of its industry peers.
  • GLPG has a Return On Equity of -17.83%. This is amongst the best in the industry. GLPG outperforms 84.70% of its industry peers.
Industry RankSector Rank
ROA -12.42%
ROE -17.83%
ROIC N/A
ROA(3y)0.68%
ROA(5y)-1.06%
ROE(3y)0.5%
ROE(5y)-2.77%
ROIC(3y)N/A
ROIC(5y)N/A
GLPG Yearly ROA, ROE, ROICGLPG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • In the last couple of years the Profit Margin of GLPG has grown nicely.
  • GLPG's Gross Margin of 84.31% is amongst the best of the industry. GLPG outperforms 87.00% of its industry peers.
  • In the last couple of years the Gross Margin of GLPG has declined.
  • GLPG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y9.7%
GM growth 3Y-4.31%
GM growth 5YN/A
GLPG Yearly Profit, Operating, Gross MarginsGLPG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • GLPG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GLPG has about the same amout of shares outstanding than it did 1 year ago.
  • GLPG has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GLPG has a worse debt to assets ratio.
GLPG Yearly Shares OutstandingGLPG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GLPG Yearly Total Debt VS Total AssetsGLPG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that GLPG is in the distress zone and has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.55, GLPG is doing good in the industry, outperforming 64.63% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that GLPG is not too dependend on debt financing.
  • GLPG has a Debt to Equity ratio (0.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACC7.95%
GLPG Yearly LT Debt VS Equity VS FCFGLPG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • GLPG has a Current Ratio of 8.63. This indicates that GLPG is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 8.63, GLPG is doing good in the industry, outperforming 76.48% of the companies in the same industry.
  • A Quick Ratio of 8.56 indicates that GLPG has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 8.56, GLPG is doing good in the industry, outperforming 76.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.63
Quick Ratio 8.56
GLPG Yearly Current Assets VS Current LiabilitesGLPG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for GLPG have decreased strongly by -311.50% in the last year.
  • GLPG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.47% yearly.
  • The Revenue for GLPG has decreased by -43.05% in the past year. This is quite bad
  • The Revenue for GLPG have been decreasing by -20.82% on average. This is quite bad
EPS 1Y (TTM)-311.5%
EPS 3YN/A
EPS 5Y-12.47%
EPS Q2Q%-298.7%
Revenue 1Y (TTM)-43.05%
Revenue growth 3Y-20.01%
Revenue growth 5Y-20.82%
Sales Q2Q%18.9%

3.2 Future

  • The Earnings Per Share is expected to decrease by -40.80% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -8.52% on average over the next years.
EPS Next Y-541.12%
EPS Next 2Y-89.82%
EPS Next 3Y-64.76%
EPS Next 5Y-40.8%
Revenue Next Year-5.4%
Revenue Next 2Y-2.5%
Revenue Next 3Y-3.52%
Revenue Next 5Y-8.52%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GLPG Yearly Revenue VS EstimatesGLPG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
GLPG Yearly EPS VS EstimatesGLPG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GLPG. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GLPG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GLPG Price Earnings VS Forward Price EarningsGLPG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLPG Per share dataGLPG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • GLPG's earnings are expected to decrease with -64.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-89.82%
EPS Next 3Y-64.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • GLPG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GALAPAGOS NV-SPON ADR

NASDAQ:GLPG (2/13/2026, 8:13:36 PM)

After market: 33.92 0 (0%)

33.92

+0.49 (+1.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)02-24
Inst Owners24.93%
Inst Owner Change0.14%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.24B
Revenue(TTM)286.92M
Net Income(TTM)-436.26M
Analysts51.58
Price Target36.88 (8.73%)
Short Float %1.89%
Short Ratio9.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10823.9%
Min EPS beat(2)-19965.4%
Max EPS beat(2)-1682.53%
EPS beat(4)1
Avg EPS beat(4)-5642.06%
Min EPS beat(4)-19965.4%
Max EPS beat(4)154.1%
EPS beat(8)4
Avg EPS beat(8)-2655.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.56%
Min Revenue beat(2)-10.27%
Max Revenue beat(2)-2.86%
Revenue beat(4)1
Avg Revenue beat(4)-5.15%
Min Revenue beat(4)-11.82%
Max Revenue beat(4)4.35%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.19%
PT rev (3m)8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)55.12%
EPS NY rev (1m)0%
EPS NY rev (3m)-78.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.56
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-7.85
EYN/A
EPS(NY)-2.13
Fwd EYN/A
FCF(TTM)-5.18
FCFYN/A
OCF(TTM)-4.85
OCFYN/A
SpS5.17
BVpS44.09
TBVpS43.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.42%
ROE -17.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.31%
FCFM N/A
ROA(3y)0.68%
ROA(5y)-1.06%
ROE(3y)0.5%
ROE(5y)-2.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y9.7%
GM growth 3Y-4.31%
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.12%
Cap/Sales 6.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.63
Quick Ratio 8.56
Altman-Z 1.55
F-Score2
WACC7.95%
ROIC/WACCN/A
Cap/Depr(3y)93.66%
Cap/Depr(5y)187.37%
Cap/Sales(3y)17.05%
Cap/Sales(5y)15.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-311.5%
EPS 3YN/A
EPS 5Y-12.47%
EPS Q2Q%-298.7%
EPS Next Y-541.12%
EPS Next 2Y-89.82%
EPS Next 3Y-64.76%
EPS Next 5Y-40.8%
Revenue 1Y (TTM)-43.05%
Revenue growth 3Y-20.01%
Revenue growth 5Y-20.82%
Sales Q2Q%18.9%
Revenue Next Year-5.4%
Revenue Next 2Y-2.5%
Revenue Next 3Y-3.52%
Revenue Next 5Y-8.52%
EBIT growth 1Y-67.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-68.33%
EBIT Next 3Y-7.6%
EBIT Next 5Y22.24%
FCF growth 1Y46.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.17%
OCF growth 3YN/A
OCF growth 5YN/A

GALAPAGOS NV-SPON ADR / GLPG FAQ

What is the fundamental rating for GLPG stock?

ChartMill assigns a fundamental rating of 2 / 10 to GLPG.


Can you provide the valuation status for GALAPAGOS NV-SPON ADR?

ChartMill assigns a valuation rating of 0 / 10 to GALAPAGOS NV-SPON ADR (GLPG). This can be considered as Overvalued.


What is the profitability of GLPG stock?

GALAPAGOS NV-SPON ADR (GLPG) has a profitability rating of 3 / 10.